Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

Abatacept may help some people with alopecia areata regrow hair.

CAR is a useful marker for assessing alopecia areata severity.

Testing for various autoantibodies in Indian children with lupus can help predict disease symptoms and risks.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Scientists made antibodies to tell cashmere and wool apart, which could improve how we identify animal fibers.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

Trichohyalin may trigger the immune response causing alopecia areata.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Avian yolk antibodies offer a promising, ethical alternative for disease prevention and therapy.

Four antibodies were developed to help study hair follicle cell differentiation.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Antibody treatments show promise for hair loss but need more research.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Alopecia areata is linked to reduced T cell function and auto-immunity.

Blocking LFA-1 prevents hair loss in mice.

Anti-keratin antibody from cow milk makes damaged hair stronger and less likely to break.

Antibodies help identify glycoproteins in normal skin and tumor cells.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

JAK inhibitors may help treat alopecia areata by reversing hair loss.